Total Payments
$7,557
2021 Payments
$716.08
Companies
43
Transactions
603
Medicare Patients
1,309
Medicare Billing
$74,021
Payment Breakdown by Category
Food & Beverage$7,403 (98.0%)
Education$153.70 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,403 | 593 | 98.0% |
| Education | $153.70 | 10 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,075 | 50 | $0 (2021) |
| PFIZER INC. | $1,005 | 103 | $0 (2020) |
| Novo Nordisk Inc | $792.94 | 74 | $0 (2021) |
| Amgen Inc. | $612.21 | 42 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $427.25 | 33 | $0 (2021) |
| Amarin Pharma Inc. | $367.24 | 29 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $351.22 | 35 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $294.56 | 27 | $0 (2021) |
| GlaxoSmithKline, LLC. | $271.32 | 22 | $0 (2019) |
| Lilly USA, LLC | $266.84 | 23 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $716.08 | 48 | AstraZeneca Pharmaceuticals LP ($154.34) |
| 2020 | $868.82 | 65 | Amarin Pharma Inc. ($211.86) |
| 2019 | $1,422 | 109 | PFIZER INC. ($282.03) |
| 2018 | $1,566 | 124 | PFIZER INC. ($388.07) |
| 2017 | $2,984 | 257 | PFIZER INC. ($323.31) |
All Payment Transactions
603 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/24/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes | ||||||
| 08/05/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLATRO | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/04/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Gastroenterology | ||||||
| 07/28/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/22/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: Diabetes | ||||||
| 06/19/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $16.52 | General |
| 06/17/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Bone Health | ||||||
| 06/14/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Diabetes | ||||||
| 06/03/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Cardiovascular | ||||||
| 05/24/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.32 | General |
| Category: Cardiovascular | ||||||
| 05/20/2021 | Roche Diagnostics Corporation | CINtec PLUS Cytology (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Tissue Diagnostics | ||||||
| 05/20/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 05/17/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
| 05/15/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $11.96 | General |
| 05/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: NEUROSCIENCE | ||||||
| 05/05/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: DIABETES | ||||||
| 04/28/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Bone Health | ||||||
| 04/27/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Respiratory | ||||||
| 04/23/2021 | UPSHER-SMITH LABORATORIES LLC | TOSYMRA (Drug), ZEMBRACE SYMTOUCH | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEUROLOGY | ||||||
| 04/12/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 04/09/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 11 | 629 | 855 | $82,050 | $34,590 |
| 2020 | 12 | 680 | 957 | $103,758 | $39,431 |
Total Patients
1,309
Total Services
1,812
Medicare Billing
$74,021
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 240 | 345 | $38,640 | $11,121 | 28.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 79 | 79 | $13,035 | $10,352 | 79.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 169 | 169 | $5,239 | $3,128 | 59.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 12 | 13 | $5,200 | $3,061 | 58.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 14 | 15 | $4,245 | $2,465 | 58.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 38 | 41 | $6,888 | $2,416 | 35.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 14 | $1,862 | $589.82 | 31.7% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 12 | 12 | $3,864 | $453.48 | 11.7% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2021 | 18 | 71 | $1,562 | $444.74 | 28.5% |
| 85610 | Blood test, clotting time | Office | 2021 | 14 | 69 | $759.00 | $296.01 | 39.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 20 | 27 | $756.00 | $262.17 | 34.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 329 | 582 | $65,184 | $15,683 | 24.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 91 | 91 | $15,015 | $10,537 | 70.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 29 | 29 | $7,250 | $4,963 | 68.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 54 | 56 | $2,632 | $2,625 | 99.8% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 16 | 18 | $5,094 | $2,482 | 48.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 58 | 60 | $2,760 | $992.49 | 36.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 13 | $2,184 | $734.17 | 33.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 24 | 24 | $744.00 | $437.52 | 58.8% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 18 | 20 | $1,080 | $396.69 | 36.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 19 | 30 | $840.00 | $289.97 | 34.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 15 | 15 | $690.00 | $247.05 | 35.8% |
| 81003 | Automated urinalysis test | Office | 2020 | 14 | 19 | $285.00 | $42.55 | 14.9% |
About Dr. Michael Shinn, MD
Dr. Michael Shinn, MD is a Family Medicine healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851398861.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Shinn, MD has received a total of $7,557 in payments from pharmaceutical and medical device companies, with $716.08 received in 2021. These payments were reported across 603 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,403).
As a Medicare-enrolled provider, Shinn has provided services to 1,309 Medicare beneficiaries, totaling 1,812 services with total Medicare billing of $74,021. Data is available for 2 years (2020–2021), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Kansas City, MO
- Active Since 07/05/2005
- Last Updated 09/26/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1851398861
Products in Payments
- FARXIGA (Drug) $764.65
- Victoza (Drug) $381.26
- Vascepa (Drug) $367.24
- CHANTIX (Drug) $354.12
- Prolia (Biological) $292.51
- XARELTO (Drug) $272.88
- Ozempic (Drug) $256.31
- LYRICA (Drug) $203.01
- SYMBICORT (Drug) $190.56
- Movantik (Drug) $187.61
- TOUJEO (Drug) $184.61
- VIAGRA (Drug) $182.10
- JARDIANCE (Drug) $160.84
- ENTRESTO (Drug) $160.41
- PREVNAR - 13 (Biological) $151.18
- EVENITY (Biological) $147.13
- TRULICITY (Drug) $145.88
- Trintellix (Drug) $140.53
- ELIQUIS (Drug) $132.09
- Aimovig (Biological) $128.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Family Medicine $38,004
Eric Aspinwall, Md, MD
Family Medicine — Payments: $33,048
Family Medicine $33,048
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Family Medicine $30,998
Dr. Blair Thedinger
Family Medicine — Payments: $19,784
Family Medicine $19,784
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Family Medicine $19,673
Teresa Marshall, M.d, M.D
Family Medicine — Payments: $19,051
Family Medicine $19,051